ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 189 filers reported holding ACORDA THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 1.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $1,096,000 | -81.3% | 142,866 | -67.6% | 0.00% | -81.8% |
| Q1 2019 | $5,858,000 | +179.8% | 440,812 | +228.0% | 0.02% | +144.4% |
| Q4 2018 | $2,094,000 | +19.9% | 134,411 | +51.1% | 0.01% | +50.0% |
| Q3 2018 | $1,747,000 | +1027.1% | 88,929 | +1549.6% | 0.01% | +500.0% |
| Q2 2018 | $155,000 | – | 5,391 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PFM Health Sciences, LP | 1,526,174 | $1,423,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 250,271 | $233,000 | 0.06% |
| Spark Investment Management LLC | 110,300 | $102,000 | 0.05% |
| SALZHAUER MICHAEL | 30,000 | $28,000 | 0.05% |
| HAP Trading, LLC | 260,800 | $532,000 | 0.04% |
| Point72 Asset Management, L.P. | 1,589,600 | $1,482,000 | 0.01% |
| DLD Asset Management, LP | 208,400 | $196,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 1,893,678 | $1,765,000 | 0.01% |
| EVERENCE CAPITAL MANAGEMENT INC | 65,680 | $61,000 | 0.01% |
| Benin Management CORP | 11,714 | $11,000 | 0.01% |